Financial Assessment of Public Health Companies in China
Author Information
Author(s): Liu Xiao, Li Yanhong, Zhang Shengnan
Primary Institution: College of Finance and Economics, Wan Jiang University of Technology, Maanshan, China
Hypothesis
This study aims to evaluate the financial risk among publicly listed companies in the public health and wellness sector in China.
Conclusion
The study reveals varied revenue trends among companies, highlighting both resilience and vulnerabilities in the public health sector.
Supporting Evidence
- The study identifies abnormal revenue patterns using Z-scores.
- Benchmarking against industry averages provides insights into competitive positioning.
- Recommendations include managing debt and increasing liquidity for long-term growth.
Takeaway
This study looks at how well five health companies in China are doing with their money and what risks they face. It helps understand how they can do better.
Methodology
The study analyzes financial performance and operational health using key performance indicators like annual revenues, liquidity ratios, and debt-to-equity ratios from 2020 to 2023.
Potential Biases
Anonymization may affect the detection of financial anomalies.
Limitations
The study is limited to five anonymized companies, which may not represent the entire public health sector.
Participant Demographics
The study focuses on publicly listed companies in the public health and wellness industry in China.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website